AstraZeneca PLCAZNNASDAQ
Loading
EV to Sales HistoryNormalizing
Percentile Rank93
3Y CAGR+0.3%
5Y CAGR+1.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+0.3%/yr
vs +0.3%/yr prior
5Y CAGR
+1.5%/yr
Consistent
Acceleration
-0.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.30 | +23.3% |
| 2024 | 4.30 | -14.2% |
| 2023 | 5.01 | -4.8% |
| 2022 | 5.26 | +2.3% |
| 2021 | 5.14 | +4.7% |
| 2020 | 4.91 | -16.4% |
| 2019 | 5.88 | +13.0% |
| 2018 | 5.20 | +19.5% |
| 2017 | 4.35 | +12.3% |
| 2016 | 3.88 | - |